Solventum Corp (SOLV): Free Cash Flow
-$10.00M
Year ended 2025-12-31
-$118.00M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$10.00M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $805.00M | -50.5% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $1.62B | +13.8% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $1.43B | n/a | 2025-02-28, From 2022-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Solventum Corp (SOLV) | 2025-12-31 | -$10.00M | n/m |
| Baxter International Inc (BAX) | 2025-12-31 | $332.00M | -42.1% |
| ResMed Inc (RMD) | 2026-06-30 | $1.65B | -0.7% |
| Dexcom Inc (DXCM) | 2025-12-31 | $1.08B | +70.8% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $3.66B | +38.3% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $2.67B | -14.4% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | -$420.00M | n/m |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $468.90M | +69.6% |
| Globus Medical Inc (GMED) | 2025-12-31 | $588.77M | +45.3% |
Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗